Updated
PfizerPFE · Healthcare
$29.39-1.64%
Market cap$167.5B
IndustryDrug Manufacturers - General
Pfizer (PFE) Superinvestor holders
38 of the superinvestors we track hold Pfizer (PFE) in their latest 13F filings, $5.4B in total.
Summary
The largest holder is Ken Fisher (Fisher Investments), with $3.2B, 0.9% of the portfolio.
In their latest quarter: 3 opened a new position, 11 added, 22 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Ken Fisher Fisher Investments |
Added | 112,118,836 | $3.2B | 0.9% | Q3 2026 |
| Josef Lakonishok LSV Asset Management |
Trimmed | 18,676,078 | $533M | 1.0% | Q3 2026 |
| Cliff Asness AQR Capital Management |
Added | 18,557,891 | $445M | 0.2% | Q2 2026 |
| Charles Brandes Brandes Investment Partners, LP |
Trimmed | 7,634,806 | $184M | 1.3% | Q2 2026 |
| Richard Pzena Pzena Investment Management |
Added | 6,050,227 | $173M | 0.5% | Q3 2026 |
| David Shaw D. E. Shaw & Co. |
Trimmed | 5,414,297 | $130M | 0.1% | Q2 2026 |
| Ensign Peak Ensign Peak Advisors |
Added | 5,127,377 | $123M | 0.2% | Q2 2026 |
| Ric Dillon Diamond Hill Capital Management |
Trimmed | 4,210,499 | $101M | 0.8% | Q2 2026 |
| Acadian Acadian Asset Management |
Trimmed | 2,740,582 | $78M | 0.1% | Q3 2026 |
| David Vogel Voloridge Investment Management |
Trimmed | 2,611,252 | $63M | 0.3% | Q2 2026 |
| Jeremy Grantham GMO |
Trimmed | 2,179,317 | $52M | 0.1% | Q2 2026 |
| Thornburg Thornburg Investment Management |
Trimmed | 1,970,004 | $47M | 0.5% | Q2 2026 |
| Sarah Ketterer Causeway Capital Management |
Added | 1,916,801 | $46M | 0.5% | Q2 2026 |
| Prem Watsa Fairfax Financial Holdings |
Added | 1,043,900 | $25M | 1.0% | Q2 2026 |
| Robert Torray Torray Investment Partners |
Added | 864,169 | $25M | 3.3% | Q3 2026 |
| Joel Greenblatt Gotham Asset Management |
Trimmed | 916,205 | $22M | 0.1% | Q2 2026 |
| Man Group Man Group plc |
Trimmed | 912,739 | $22M | 0.0% | Q2 2026 |
| Paul Marshall Marshall Wace |
Trimmed | 802,396 | $19M | 0.0% | Q2 2026 |
| Paul Tudor Jones Tudor Investment Corp |
New position | 697,000 | $17M | 0.1% | Q2 2026 |
| Mario Gabelli GAMCO Investors |
Trimmed | 571,286 | $14M | 0.1% | Q2 2026 |
| Thomas Kahn Kahn Brothers Group |
Trimmed | 464,001 | $11M | 1.8% | Q2 2026 |
| Two Sigma Two Sigma Investments |
Added | 330,300 | $8M | 0.0% | Q2 2026 |
| Neil Hennessy Hennessy Advisors |
Trimmed | 228,900 | $7M | 0.2% | Q3 2026 |
| Fayez Sarofim Fayez Sarofim & Co |
Added | 233,339 | $6M | 0.0% | Q2 2026 |
| Bruce Berkowitz Fairholme Capital Management |
New position | 231,000 | $6M | 0.4% | Q2 2026 |
| Ray Dalio Bridgewater Associates |
New position | 180,092 | $4M | 0.0% | Q2 2026 |
| First Manhattan First Manhattan Co |
Trimmed | 178,070 | $4M | 0.0% | Q2 2026 |
| Alger Fred Alger Management |
Trimmed | 128,336 | $3M | 0.0% | Q2 2026 |
| Mark Boyar Boyar Asset Management |
Trimmed | 88,524 | $3M | 1.6% | Q3 2026 |
| Fred DiSanto Ancora Holdings |
Trimmed | 88,780 | $2M | 0.0% | Q2 2026 |
| Dodge & Cox | Trimmed | 87,814 | $2M | 0.0% | Q2 2026 |
| Alan Breed Edgewood Management |
Held | 82,179 | $2M | 0.0% | Q2 2026 |
| Murray Stahl Horizon Kinetics LLC |
Added | 69,662 | $2M | 0.0% | Q2 2026 |
| Mairs & Power Mairs & Power Inc |
Trimmed | 67,679 | $2M | 0.0% | Q2 2026 |
| Alan Howard Brevan Howard |
Added | 49,400 | $1M | 0.0% | Q2 2026 |
| Howard Gleicher Aristotle Capital Management |
Held | 46,072 | $1M | 0.0% | Q2 2026 |
| Hersh Cohen ClearBridge Investments |
Trimmed | 43,369 | $1M | 0.0% | Q2 2026 |
| Aziz Hamzaogullari Loomis Sayles & Co |
Trimmed | 7,500 | $180,600 | 0.0% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 38 |
| Q1 2026 | 36 |
| Q4 2025 | 38 |
| Q3 2025 | 37 |
| Q2 2025 | 38 |
| Q1 2025 | 46 |
| Q4 2024 | 40 |
| Q3 2024 | 41 |
Questions about Pfizer
Which superinvestors own Pfizer?
38 of the superinvestors we track hold Pfizer (PFE) in their latest 13F filings, $5.4B in total. Ken Fisher, Josef Lakonishok, Cliff Asness, Charles Brandes, Richard Pzena, David Shaw.
Who is the largest superinvestor holder of PFE?
The largest holder is Ken Fisher (Fisher Investments), with $3.2B, 0.9% of the portfolio.
From Pfizer's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.